GAO Report on DOD Efforts to Develop Domestic Biomanufacturing

This U.S. GAO report, GAO-26-107797, published on February 26, 2026, reviews the Department of Defense's (DOD) initiatives to foster domestic biomanufacturing. The report highlights that DOD has invested approximately $965.2 million since 2021 across three key initiatives aimed at maturing biotechnology projects from laboratory to commercial-scale production and establishing domestic supply chains. These efforts include investing in projects from military labs, collaborating with industry to build biomanufacturing facilities, and supporting industry partners in constructing commercial-scale production facilities. The report notes that DOD plans to end two of these initiatives after fiscal years 2027 and 2028, respectively, and that a forthcoming biotechnology roadmap will provide further insights into future strategic investment priorities.

While this report is primarily informational and does not impose new direct compliance obligations on regulated entities, it signals the U.S. government's strategic focus on strengthening the domestic defense industrial base through advanced manufacturing technologies like biomanufacturing. Companies involved in biotechnology, advanced materials, or defense supply chains should be aware of DOD's ongoing investments and strategic direction. The report indicates that DOD expects to complete a roadmap of future plans in 2026, which may lead to future funding opportunities or policy developments in this sector.